Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125716481 | 12571648 | 1 | I | 201507 | 20150825 | 20160719 | 20160719 | PER | US-BAUSCH-BL-2015-020286 | BAUSCH AND LOMB | 69.31 | YR | F | Y | 63.56000 | KG | 20160719 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125716481 | 12571648 | 1 | PS | XIFAXAN | RIFAXIMIN | 1 | Oral | 21361 | 550 | MG | TABLET | BID | |||||||
| 125716481 | 12571648 | 2 | SS | URSODIOL. | URSODIOL | 1 | Oral | 0 | 300 | MG | TID | ||||||||
| 125716481 | 12571648 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 20 | MG | QD | |||||||||
| 125716481 | 12571648 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 600 | MG | QD | ||||||||
| 125716481 | 12571648 | 5 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 0 | |||||||||||
| 125716481 | 12571648 | 6 | C | CARAFATE | SUCRALFATE | 1 | Oral | 0 | 10 | ML | QID | ||||||||
| 125716481 | 12571648 | 7 | C | NADOLOL. | NADOLOL | 1 | Oral | 0 | |||||||||||
| 125716481 | 12571648 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | |||||||||||
| 125716481 | 12571648 | 9 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | |||||||||||
| 125716481 | 12571648 | 10 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | |||||||||||
| 125716481 | 12571648 | 11 | C | CHOLESTYRAMINE. | CHOLESTYRAMINE | 1 | Oral | 1 PACKET DAILY FOR 7 DAYS AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125716481 | 12571648 | 1 | Hepatic encephalopathy |
| 125716481 | 12571648 | 2 | Hepatic cirrhosis |
| 125716481 | 12571648 | 3 | Varices oesophageal |
| 125716481 | 12571648 | 4 | Restless legs syndrome |
| 125716481 | 12571648 | 5 | Varices oesophageal |
| 125716481 | 12571648 | 6 | Varices oesophageal |
| 125716481 | 12571648 | 7 | Hepatic cirrhosis |
| 125716481 | 12571648 | 8 | Depression |
| 125716481 | 12571648 | 9 | Supplementation therapy |
| 125716481 | 12571648 | 10 | Supplementation therapy |
| 125716481 | 12571648 | 11 | Pruritus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125716481 | 12571648 | Alopecia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125716481 | 12571648 | 1 | 20150609 | 0 | ||
| 125716481 | 12571648 | 2 | 201405 | 0 | ||
| 125716481 | 12571648 | 3 | 201505 | 0 | ||
| 125716481 | 12571648 | 5 | 201505 | 0 | ||
| 125716481 | 12571648 | 6 | 201506 | 0 | ||
| 125716481 | 12571648 | 10 | 2015 | 0 | ||
| 125716481 | 12571648 | 11 | 201506 | 0 |